| 08:30 - 10:30 | 181 | Paediatric year in review | Hot topics |
| 08:30 - 10:30 | 182 | Multigenic expression analyses: a guide for diagnosis and therapy | Symposium |
| 08:30 - 10:30 | 183 | Defining COPD using the "fixed ratio" (FEV1/FVC <0.70) – pro and con | Symposium |
| 08:30 - 10:30 | 184 | Multidisciplinary approach in interstitial lung disease | Symposium |
| 08:30 - 10:30 | 185 | Chest physiotherapy in the intensive care unit | Symposium |
| 08:30 - 10:30 | 186 | Treating cough | Symposium |
| 08:30 - 10:30 | 187 | Therapy in thoracic oncology | Oral Presentation |
| 08:30 - 10:30 | 188 | Factors related to outcome of community-acquired pneumonia | Oral Presentation |
| 08:30 - 10:30 | 189 | New frontiers in noninvasive assessment of the lungs | Oral Presentation |
| 08:30 - 10:30 | 190 | Environmental tobacco smoke and smoking ban | Oral Presentation |
| 08:30 - 10:30 | 191 | Pulmonary vascular medicine | Oral Presentation |
| 08:30 - 10:30 | 192 | New trends in interventional pulmonology | Oral Presentation |
| 08:30 - 10:30 | 193 | Clinical epidemiology of tuberculosis | Oral Presentation |
| 08:30 - 10:30 | 194 | Diagnostic aspects of sleep apnoea | E-Communication Session |
| 08:30 - 10:30 | 195 | Lung and bone marrow transplantation: miscellaneous | E-Communication Session |
| 08:30 - 10:30 | 196 | Risk factors for allergic asthma and allergic rhinitis | E-Communication Session |
| 08:30 - 10:30 | 197 | Pleural diseases and interventions | E-Communication Session |
| 08:30 - 10:30 | 198 | Border patrol: the alveolar barrier in lung injury | E-Communication Session |
| 10:45 - 12:45 | 199 | Thoracic Oncology Grand Round - an interactive session | Grand round |
| 10:45 - 12:45 | 200 | Update on lung transplantation 2008 | Symposium |
| 10:45 - 12:45 | 201 | Impact of nursing interventions on the quality of care for COPD patients | Symposium |
| 10:45 - 12:45 | 202 | “Omics” and systems biology: the promise of future disease understanding | Symposium |
| 10:45 - 12:45 | 203 | Priorities for tuberculosis research in Europe: discussing the results of the Tuberculosis Network European Trials Group (TBNET) | Symposium |
| 10:45 - 12:45 | 204 | Noninvasive positive pressure in heart failure - where are we now with two large multicentre studies showing no apparent benefit? | Hot topics |
| 10:45 - 12:45 | 205 | Preschool wheezing: advances in diagnosis, phenotyping and therapy | Oral Presentation |
| 10:45 - 12:45 | 206 | Lung, traffic and volcanoes | Oral Presentation |
| 10:45 - 12:45 | 207 | Novel mechanisms in the pathogenesis of pulmonary inflammation | Oral Presentation |
| 10:45 - 12:45 | 208 | Alternatives for continuous positive airway pressure therapy in obstructive sleep apnoea | Oral Presentation |
| 10:45 - 12:45 | 209 | Effects of rehabilitation in very disabled COPD patients | Oral Presentation |
| 10:45 - 12:45 | 210 | Best of lung epithelial cells 2008 | Oral Presentation |
| 10:45 - 12:45 | 211 | Management of COPD | Oral Presentation |
| 10:45 - 12:45 | 212 | Mucociliary clearance, novel techniques and assessments, in adult, paediatric and mechanically ventilated patients | E-Communication Session |
| 10:45 - 12:45 | 213 | Diagnostic paediatric lung function: technical and clinical aspects | E-Communication Session |
| 10:45 - 12:45 | 214 | Inflammatory trigger mechanisms in asthma and COPD | E-Communication Session |
| 10:45 - 12:45 | 215 | COPD epidemiology | E-Communication Session |
| 10:45 - 12:45 | 216 | Treatment and outcome in hospitalised patients with community-acquired pneumonia | E-Communication Session |
| 12:50 - 14:40 | 218 | Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease | Thematic Poster Session |
| 12:50 - 14:40 | 219 | Interstitial lung disease in systemic and vascular disorders | Thematic Poster Session |
| 12:50 - 14:40 | 220 | Acute lung injury and weaning | Thematic Poster Session |
| 12:50 - 14:40 | 221 | Mechanical ventilation and airway management | Thematic Poster Session |
| 12:50 - 14:40 | 222 | Noninvasive mechanical ventilation in the acute setting | Thematic Poster Session |
| 12:50 - 14:40 | 223 | Noninvasive ventilation in the chronic setting | Thematic Poster Session |
| 12:50 - 14:40 | 224 | Basic science in asthma and COPD II | Thematic Poster Session |
| 12:50 - 14:40 | 225 | Airway infection and host defence | Thematic Poster Session |
| 12:50 - 14:40 | 226 | Improving asthma and anti-allergic therapy | Thematic Poster Session |
| 12:50 - 14:40 | 227 | Understanding allergic airway inflammation with the help of animal models | Thematic Poster Session |
| 12:50 - 14:40 | 228 | Epidemiology of respiratory symptoms and COPD | Thematic Poster Session |
| 12:50 - 14:40 | 229 | Smoking cessation and new tobacco uses | Thematic Poster Session |
| 12:50 - 14:40 | 230 | Risk factors for childhood asthma and allergy | Thematic Poster Session |
| 12:50 - 14:40 | 231 | Pleuropulmonary infections; thoracic trauma | Thematic Poster Session |
| 12:50 - 14:40 | 232 | Diagnostic and therapeutic problems in thoracic surgery | Thematic Poster Session |
| 12:50 - 14:40 | 233 | Mediastinal lesions; rare pathology | Thematic Poster Session |
| 12:50 - 14:40 | 234 | Surgical treatment of lung tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 235 | Donor organs and complications after lung transplantation | Thematic Poster Session |
| 12:50 - 14:40 | 236 | Beyond spirometry: the skills behind lung function testing | Thematic Poster Session |
| 12:50 - 14:40 | 237 | Diagnostic tests in lower respiratory tract infections | Thematic Poster Session |
| 12:50 - 14:40 | 238 | Lower respiratory tract infection: from outbreak to prognostic tests | Thematic Poster Session |
| 12:50 - 14:40 | 239 | Community-acquired pneumonia: prognosis, complications and prevention | Thematic Poster Session |
| 12:50 - 14:40 | 240 | Aetiology of respiratory infections: mycobacteria and fungi | Thematic Poster Session |
| 12:50 - 14:40 | 241 | Mechanisms of respiratory infections: interaction between the pathogen and the host | Thematic Poster Session |
| 12:50 - 14:40 | 242 | Features of hospital-acquired pneumonia, ventilator-associated pneumonia and infection with other pathogens | Thematic Poster Session |
| 12:50 - 14:40 | 243 | Clinical epidemiology of tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 244 | Tuberculosis in immigrants, disadvantaged populations, elderly, HIV-seropositives and in other risk groups | Thematic Poster Session |
| 12:50 - 14:40 | 245 | Problems in managing pulmonary and extrapulmonary tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 246 | Diagnosis of tuberculosis: problems and perspectives | Thematic Poster Session |
| 12:50 - 14:40 | 247 | Outcomes of tuberculosis treatment | Thematic Poster Session |
| 12:50 - 14:40 | 248 | Specific tuberculosis management problems in children and adolescents | Thematic Poster Session |
| 12:50 - 14:40 | 249 | Clinical epidemiology of tuberculosis I | Thematic Poster Session |
| 12:50 - 14:40 | 250 | Clinical epidemiology of tuberculosis II | Thematic Poster Session |
| 12:50 - 14:40 | 251 | Clinical epidemiology of tuberculosis III | Thematic Poster Session |
| 12:50 - 14:40 | 252 | The challenge of multidrug-resistant tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 253 | Interferon-gamma release assay tests for diagnosing tuberculosis infection and disease | Thematic Poster Session |
| 12:50 - 14:40 | 254 | Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis | Thematic Poster Session |
| 12:50 - 14:40 | 255 | Difficult tuberculosis cases | Thematic Poster Session |
| 12:50 - 14:40 | 256 | Various thoracic tumours and interesting cases | Thematic Poster Session |
| 12:50 - 14:40 | 257 | Biology and prognosis in thoracic oncology | Thematic Poster Session |
| 12:50 - 14:40 | 258 | Diagnostic aspects in thoracic oncology | Thematic Poster Session |
| 12:50 - 14:40 | 259 | Treatment of thoracic tumours | Thematic Poster Session |
| 12:50 - 14:40 | 260 | Various aspects of thoracic oncology | Thematic Poster Session |
| 12:50 - 14:40 | 261 | Impact of patient education on cost-effectiveness of treatment | Thematic Poster Session |
| 13:00 - 14:30 | 263 | A step-change in asthma. The Lancet/ERS symposium | Hot topics |
| 13:00 - 14:00 | 266 | Clinical trial - The effects of an anti-IL-13 human monoclonal antibody, IMA-638, on allergen-induced airway responses in subjects with mild atopic asthma | Symposium |
| 13:00 - 14:30 | 267 | Lunchtime programme: The EU Innovative Medicines Initiative (IMI) - a new "pre-competitive" strategy for enhanced drug development in Europe | Symposium |
| 13:00 - 14:30 | 270 | Lunchtime programme: Berlin - views and insights guided by the history of medicine | Symposium |
| 13:00 - 14:30 | 271 | Practical workshop: Practical aspects of applying noninvasive ventilation from acute to chronic | Practical Workshop |
| 13:00 - 14:30 | 273 | Lunchtime programme: Educational seminar - Harmonising standards for education and training in respiratory medicine: prospects and challenges | Symposium |
| 13:00 - 14:00 | 274 | MP7 - Diagnostic approach to pleural effusions | Meet the Professor |
| 13:00 - 14:00 | 276 | MP9 - Home mechanical ventilation initiation | Meet the Professor |
| 13:00 - 14:00 | 277 | MP10 - Allergen immunotherapy in paediatric respiratory disease | Meet the Professor |
| 14:45 - 16:45 | 281 | Clinical Grand Round - an interactive session | Grand round |
| 14:45 - 16:45 | 282 | Patient-ventilator interactions during ventilation | Symposium |
| 14:45 - 16:45 | 283 | Malignant pleural mesothelioma: new aspects in treatment and aetiology | Symposium |
| 14:45 - 16:45 | 284 | New insights into COPD pathophysiology | Symposium |
| 14:45 - 16:45 | 285 | Computer-aided imaging of lung parenchyma and airways | Symposium |
| 14:45 - 16:45 | 286 | The battle between environmental “invaders” and airway epithelial defences | Symposium |
| 14:45 - 16:45 | 287 | Novel treatments for respiratory disease | Oral Presentation |
| 14:45 - 16:45 | 288 | Rehabilitation and influencing factors | Oral Presentation |
| 14:45 - 16:45 | 289 | Biomarkers and antibiotic treatment of exacerbations of COPD | Oral Presentation |
| 14:45 - 16:45 | 290 | Genetic risk factors for asthma and COPD | Oral Presentation |
| 14:45 - 16:45 | 291 | Pulmonary infections in children - rare but important aspects | Oral Presentation |
| 14:45 - 16:45 | 292 | Pathogenesis of obstructive sleep apnoea | Oral Presentation |
| 14:45 - 16:45 | 293 | Discovery of novel targets in lung disease by means of functional genomics | Oral Presentation |
| 14:45 - 16:45 | 294 | Asthma control or asthma severity | E-Communication Session |
| 14:45 - 16:45 | 295 | Integrated care and long-term strategies | E-Communication Session |
| 14:45 - 16:45 | 296 | Congenital lung lesions and emphysema; lung cancer surgery | E-Communication Session |
| 14:45 - 16:45 | 297 | New tests and methods to diagnose tuberculosis infection and disease and to monitor treatment | E-Communication Session |
| 14:45 - 16:45 | 298 | Cystic fibrosis: new mechanisms, monitoring and treatment tools | E-Communication Session |
| 17:15 - 19:15 | 302 | Update on long-term oxygen therapy in COPD | Evening Symposium |
| 17:15 - 19:15 | 305 | Current and future pulmonary arterial hypertension combination therapy | Evening Symposium |
| 17:15 - 19:15 | 309 | Why vaccinate patients with chronic respiratory conditions? Today and tomorrow's perspectives | Evening Symposium |